Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose IL-2 in Primary Sjögren's Syndrome
NCT02464319Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jun 2015
- Primary completion
- Mar 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in primary Sjögren's syndrome, sponsored by Peking University People's Hospital. Started Jun 2015; status: completed.
02
Drugs
aldesleukin
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT02464319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464319.